logo-loader
NASDAQ:ACRS

Aclaris Therapeutics Inc.

Receive alerts
Market:
NASDAQ
Price
3.50 USD
Day Change
3.55%
Market Cap:
$555.14 m
52 weeks high
6.59
52 weeks low
2.36

In brief

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine.